MedCap AB (publ) (STO:MCAP)

MedCap AB Balance Sheet

Financials in millions SEK. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	272.8	370.4	370.1	188.2	236.2	139.7
Cash & Short-Term Investments	272.8	370.4	370.1	188.2	236.2	139.7
Cash Growth	-23.95%	0.08%	96.65%	-20.32%	69.08%	-4.64%
Accounts Receivable	316.4	267.3	210.6	237	169.3	137.9
Other Receivables	110.4	52.9	41	47.4	155.6	33.2
Receivables	426.8	320.2	251.6	284.4	324.9	171.1
Inventory	324.8	271.4	268.9	276.7	162.7	150.2
Prepaid Expenses	-	9.2	8.6	6.5	4.6	5.4
Other Current Assets	-	20.2	18.2	9.4	13.5	8.5
Total Current Assets	1,024	991.4	917.4	765.2	741.9	474.9
Property, Plant & Equipment	364.7	379.2	402.8	243.9	242.6	253.8
Goodwill	769.5	662.7	362.2	339.9	242.6	229.5
Other Intangible Assets	624.6	455.4	242.6	261.5	154.4	172
Long-Term Deferred Tax Assets	12	5.1	3.6	3.4	3.1	2.7
Long-Term Deferred Charges	-	110.9	62.2	47.8	44.5	36.3
Other Long-Term Assets	1.5	1.3	0.6	0.5	0.2	0.3
Total Assets	2,797	2,606	1,991	1,662	1,429	1,170

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	426.1	107.9	72.7	90.6	75.8	50
Accrued Expenses	-	80.2	75.8	77.1	42.7	42.8
Short-Term Debt	-	-	-	17.9	46.2	43.7
Current Portion of Long-Term Debt	43.3	59.3	25.2	24.1	42	23.3
Current Portion of Leases	42.2	42.9	35.4	27	27.9	24.5
Current Income Taxes Payable	88.9	41.5	42.1	46.7	21	10.1
Current Unearned Revenue	-	1.8	2.7	1.2	0.1	0.3
Other Current Liabilities	-	160.7	77.6	58.4	46.4	47.2
Total Current Liabilities	600.5	494.3	331.5	343	302.1	241.9
Long-Term Debt	151	156.6	48.8	72	96	18.3
Long-Term Leases	201.2	224.1	248.6	120.2	127.9	147.1
Long-Term Deferred Tax Liabilities	126.3	113.1	62.1	66.7	39	38.1
Other Long-Term Liabilities	8.2	159	12.2	33.2	5.6	26.4
Total Liabilities	1,087	1,147	703.2	635.1	570.6	471.8

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	6.03	6	6	5.9	5.9	5.9
Additional Paid-In Capital	-	492.3	464	428.2	428.2	428.2
Retained Earnings	-	978.3	783.6	576	402	262.2
Comprehensive Income & Other	1,702	-24.5	28.4	12.8	20.2	-0.3
Total Common Equity	1,708	1,452	1,282	1,023	856.3	696
Minority Interest	1.8	6.8	6.2	4.2	2.4	1.7
Shareholders' Equity	1,710	1,459	1,288	1,027	858.7	697.7
Total Liabilities & Equity	2,797	2,606	1,991	1,662	1,429	1,170

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	437.7	482.9	358	261.2	340	256.9
Net Cash (Debt)	-164.9	-112.5	12.1	-73	-103.8	-117.2
Net Cash Growth	-	-	-	-	-	-
Net Cash Per Share	-11.01	-7.50	0.81	-4.91	-7.01	-7.92
Filing Date Shares Outstanding	14.98	15.02	14.97	14.81	14.81	14.81
Total Common Shares Outstanding	14.98	15.02	14.97	14.81	14.81	14.81
Working Capital	423.9	497.1	585.9	422.2	439.8	233
Book Value Per Share	114.03	96.68	85.62	69.08	57.83	47.00
Tangible Book Value	313.6	334	677.2	421.5	459.3	294.5
Tangible Book Value Per Share	20.94	22.24	45.23	28.47	31.02	19.89
Machinery	-	357.2	344.7	295	246.4	216.3

Data Source: S&P Global Market Intelligence Last updated: Oct 23, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 3, 2026

Data Sources Report a data error